Cue Biopharma, Inc. Income Taxes Paid
Cue Biopharma, Inc. (CUE) reported Income Taxes Paid of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2022-11-14
- Cue Biopharma, Inc. income taxes paid for the quarter ending 2022-09-30 was $0.00.
- Cue Biopharma, Inc. income taxes paid for the quarter ending 2021-09-30 was $0.00.
- Cue Biopharma, Inc. income taxes paid for the quarter ending 2021-06-30 was $0.00.
- Cue Biopharma, Inc. income taxes paid for the quarter ending 2021-03-31 was $206.00K.
- Cue Biopharma, Inc. income taxes paid for fiscal 2019 was $412.50K, a 50.00% decline from fiscal 2018.
- Cue Biopharma, Inc. income taxes paid for fiscal 2018 was $825.00K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $206.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $206.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $206.00K 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | -$500.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$500.00 derived: sum of 2 quarters · filed 2021-03-09 | $412.50K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $413.00K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $413.00K 10-Q · filed 2020-08-07 | |||
| 2018-12-31 | $825.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |